2-65071737-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015147.3(CEP68):c.641C>T(p.Ala214Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,613,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015147.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP68 | NM_015147.3 | c.641C>T | p.Ala214Val | missense_variant | 3/7 | ENST00000377990.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP68 | ENST00000377990.7 | c.641C>T | p.Ala214Val | missense_variant | 3/7 | 1 | NM_015147.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152156Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000136 AC: 34AN: 250724Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135532
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461606Hom.: 0 Cov.: 34 AF XY: 0.0000495 AC XY: 36AN XY: 727098
GnomAD4 genome AF: 0.000177 AC: 27AN: 152156Hom.: 0 Cov.: 31 AF XY: 0.000161 AC XY: 12AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.641C>T (p.A214V) alteration is located in exon 3 (coding exon 2) of the CEP68 gene. This alteration results from a C to T substitution at nucleotide position 641, causing the alanine (A) at amino acid position 214 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at